ストックスクリーナーアプリを入手
31.48
1.61%
0.50
アフターアワーズ：
31.48
Baxter International Inc (BAX) 最新ニュース
Earnings Preview: What To Expect From Baxter International's Report - Nasdaq
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
China Infusion Systems (Pumps & Pump Disposables) Market Outlook to 2033: Key Companies in China, Pipeline Products, Financial Deals Landscape, Recent Developments & More - GlobeNewswire Inc.
Baxter restarts dialysis solutions production at North Cove plant - MSN
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Hold Baxter International (BAX) for the Long Term? - MSN
Baxter International Inc. (NYSE:BAX) Receives $40.45 Consensus Price Target from Analysts - MarketBeat
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Small divestitures, acquisitions ahead as Baxter refines strategy - Crain's Chicago Business
Infusion Therapy Market Growth Trends: Regional Breakdown - openPR
Baxter International Inc. (NYSE:BAX) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Baxter International (XSWX:BAX) 3-Year EPS without NRI Grow - GuruFocus.com
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Unparalleled Research on Immunoglobulin Market by 2024-2031 | Baxter international Inc., CSL Ltd. - EIN News
U.S. Elastomeric Infusion Pumps Market Set to Witness Significant Growth by 2025-2032: Baxter International - EIN News
U.S. Intravenous Solutions Market Is Booming Worldwide - openPR
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
How Italian Furniture Maker Baxter Balances Tradition and Innovation - Prestige Online Thailand
Baxter International Inc. stock rises Monday, still underperforms market - MarketWatch
Immunoglobulin Market Generated Opportunities, Future Scope by 2024-2031| Baxter international Inc., CSL Ltd. - EIN News
Baxter International Inc. (NYSE:BAX) Shares Sold by Everence Capital Management Inc. - MarketBeat
Plasma Expander Market Overall Study Report 2025-2032 | Baxter - openPR
Baxter International Inc. stock rises Friday, still underperforms market - MarketWatch
Centre Asset Management LLC Sells 21,904 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. (NYSE:BAX) Short Interest Up 6.1% in December - MarketBeat
Earnings Review and Free Research Report: Baxter’s Revenue Grew 6%; EPS Rocketed 96% - AccessWire
BAXTER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Baxter International In - AccessWire
How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks? - MSN
Investors in Baxter International (NYSE:BAX) have unfortunately lost 64% over the last three years - Simply Wall St
Early Alert: Solution Set Issue from Baxter Healthcare Corporation - FDA.gov
Baxter International (NYSE:BAX) Sets New 52-Week LowWhat's Next? - MarketBeat
Baxter stock touches 52-week low at $28.6 amid market challenges - Investing.com Australia
Should We Be Cautious About Baxter International Inc.'s (NYSE:BAX) ROE Of 1.6%? - Yahoo Finance
Prolotherapy Market Overall Study Report 2024-2031 | Pfizer - openPR
0.92%
1.54%
大文字化:
|
ボリューム (24 時間):